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Objective: To evaluate the clinical effectiveness of manual physiotherapy and/or exercise physiotherapy in
addition to usual care for patients with osteoarthritis (OA) of the hip or knee.
Design: In this 2  2 factorial randomized controlled trial, 206 adults (mean age 66 years) who met the
American College of Rheumatology criteria for hip or knee OAwere randomly allocated to receive manual
physiotherapy (n ¼ 54), multi-modal exercise physiotherapy (n ¼ 51), combined exercise and manual
physiotherapy (n ¼ 50), or no trial physiotherapy (n ¼ 51). The primary outcome was change in the
Western Ontario and McMaster osteoarthritis index (WOMAC) after 1 year. Secondary outcomes included
physical performance tests. Outcome assessors were blinded to group allocation.
Results: Of 206 participants recruited, 193 (93.2%) were retained at follow-up. Mean (SD) baseline
WOMAC score was 100.8 (53.8) on a scale of 0e240. Intention to treat analysis showed adjusted re-
ductions in WOMAC scores at 1 year compared with the usual care group of 28.5 (95% conﬁdence interval
(CI) 9.2e47.8) for usual care plus manual therapy, 16.4 (3.2 to 35.9) for usual care plus exercise therapy,
and 14.5 (5.2 to 34.1) for usual care plus combined exercise therapy and manual therapy. There was an
antagonistic interaction between exercise therapy and manual therapy (P ¼ 0.027). Physical performance
test outcomes favoured the exercise therapy group.
Conclusions: Manual physiotherapy provided beneﬁts over usual care, that were sustained to 1 year.
Exercise physiotherapy also provided physical performance beneﬁts over usual care. There was no added
beneﬁt from a combination of the two therapies.
Trial registration number: Australian New Zealand Clinical Trials Registry ACTRN12608000130369.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Non-pharmacological, non-surgical interventions, primarily
exercise therapy and more recently manual therapy, are recom-
mended as the ﬁrst line of treatment for hip and knee osteoarthritisJ.H. Abbott, Centre for Mus-
cal Sciences, Dunedin School
9054, New Zealand. Tel: 64-
haxby.abbott@otago.ac.nz
s Research Society International. P(OA). However there is little evidence for the long-term effective-
ness of exercise therapy, and there is insufﬁcient evidence on the
effectiveness of manual therapy1.
It is well established that various forms of exercise are effective
in reducing pain and increasing physical function in people with
hip or knee OA. However, there is little knowledge about which
forms of exercise provide the greatest and most enduring beneﬁt,
with few studies having followed participants to or beyond 12
months2,3.
Newdevelopments inmanual physiotherapyhavedemonstrated
promising improvements in pain and physical function for hip and
knee OA4e7, but effectiveness has not yet been established8,9.ublished by Elsevier Ltd. All rights reserved.
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andpain byaddressing impairedkinematics of the joint,which inOA
can be affected by joint capsule contracture, loss of periarticular
ﬂexibility, and increased intracapsular pressure10. On the strength of
just one randomised clinical trial, the 2008 NICE clinical guideline
for OA recommends that manual therapy should “be considered an
adjunct to core treatment” for hip OA1. No randomized controlled
trial has investigated the beneﬁts of manual therapy in addition to
usual care alone, in patients with hip or knee OA.
The Management of OsteoArthritis (MOA) Trial investigated the
long-term effectiveness of: (1) an individualised manual physi-
otherapy programme in addition to usual care; (2) a multi-modal,
individualised, supervised exercise physiotherapy programme inFig. 1. Flow of participants through the trial. Note: all participantsaddition to usual care; and (3) a combination of both programmes
in addition to usual care; compared with usual care only, for the
management of pain and disability in adults with hip or knee OA.
Methods
Trial design
Thiswasa22 factorial randomizedcontrolled trialwitha1-year
follow-up (Fig. 1). The trial protocol has been published in advance11
and the trial was registered on the Australian New Zealand Clinical
Trials Registry ACTRN12608000130369. The study was approved by
the Lower South Regional Ethics Committee of the New Zealandcontinued to receive usual medical care throughout the trial.
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with the Declaration of Helsinki.
Participants
We recruited participants through two sources: (1) general
practitioner (GP) referral of patients with hip or knee OA, and (2)
patients referred by their GP to a hospital orthopaedic outpatient
clinic for an orthopaedic consultation to consider hip or knee joint
replacement surgery. We recruited only patients not waitlisted for
surgery. We assured participants that involvement in the trial
would not affect their potential future access to the joint replace-
ment waiting list. Recruitment took place in Dunedin, New Zealand.
To be eligible, participants were required tomeet clinical criteria
for diagnosis of OA of the hip or knee established by the American
College of Rheumatology12e14. Exclusion criteria were rheumatoid
arthritis; previous knee or hip joint replacement surgery of the
affected joint; any other surgical procedure on the lower limbs in
the previous 6 months; surgical procedure on the lower limbs
planned in the next 6 months; initiation of opioid analgesia or
corticosteroid or analgesic injection intervention for hip or knee
pain within the previous 30 days; physical impairments unrelated
to the hip or knee which would prevent safe participation in ex-
ercise, manual therapy, walking or stationary cycling; inability to
comprehend and complete study assessments or comply with
study instructions; or stated inability to attend or complete the
proposed course of intervention and follow-up schedule11.
Procedures
A research nurse contacted then screened each potential par-
ticipant against the inclusion and exclusion criteria by chart review
and questioning by telephone. Potential participants attended an
appointment, where we conﬁrmed eligibility and obtained written
informed consent and baseline measures.
Randomisation and allocation concealment
After baseline assessment, participants were randomised using
TENALEA, an online randomisation service15. Randomisation was
stratiﬁed by condition (hip or knee). Within each stratum, partici-
pants were randomised to one of the four intervention groups us-
ing block allocation. The block sizewas subject to randomvariation.
The TENALEA service generated and held the randomisation
schedule, ensuring allocation concealment.
Blinding
Outcome assessors were blind to group allocation, and were not
involved in providing the interventions. The orthopaedic surgeons
and GPs managing the participants’ care were blind to group allo-
cation. The statisticians conducting the statistical analyses were
blind to group allocation until after the analyses were completed.
Interventions
Usual care
All participants continued to receive routine care offered by
their own GP and other healthcare providers. No trial interventions
were provided. We neither inﬂuenced nor restricted GPs’, sur-
geons’, other practitioners’ or participants’ use of other in-
terventions (although we did monitor it, and report this separately
in the economic evaluation conducted alongside this trial16).
Participants allocated to the active intervention groups received
the following interventions in addition to usual care.Manual physiotherapy
The manual therapy protocol consisted of procedures intended
to modify the quality and range of motion of the target joint and
associated soft tissue structures. Additional manual therapy in-
terventions were prescribed individually for each participant
randomised to this intervention on the basis of the physical ex-
amination ﬁndings, from a limited list of interventions deﬁned in
our protocol (see Appendix 1). In addition we prescribed a home
programme of joint range of motion activities to be completed
three times per week. The manual therapy protocol did not provide
or prescribe aerobic, strengthening or neuromuscular control
exercises.
Exercise physiotherapy
The exercise therapy protocol consisted of a multi-modal, su-
pervised programme of warm-up/aerobic, muscle strengthening,
muscle stretching, and neuromuscular control exercises. Additional
exercise therapy interventions were prescribed individually for
each participant on the basis of the physical examination ﬁndings,
from a limited list of interventions (see Appendix 1). In additionwe
prescribed a home exercise programme to be completed three
times per week. The exercise therapy protocol did not allow
therapist-applied manual forces.
Combination therapy
This consisted of a combination of both manual therapy and
exercise therapy interventions, as described above.
Physiotherapy sessions
Each participant in one of the three intervention groups atten-
ded nine treatment sessions of approximately 50 min: seven in the
initial 9 weeks of the trial and two ‘booster’ sessions at week 16.
The interventions were provided at a university research clinic.
Registered physiotherapists employed by the institution were eli-
gible to be providers, were integral to the development of the
therapy protocols over 3 days, and were additionally provided with
approximately 6 h training. Six physiotherapists provided in-
terventions. Audits were conducted of provider adherence to
therapy protocols.
Outcome measures
Primary
The primary outcome was change in the composite Western
Ontario and McMaster osteoarthritis index (WOMAC) at 1-year
follow-up17.
Secondary
Secondary outcome measures, recommended by Outcome
Measures in Rheumatoid Arthritis Clinical Trials e Osteoarthritis
Research Society International (OMERACTeOARSI) guidelines,
included measures of pain, physical function and patient global
assessment18e21. Physical function was assessed using the timed
up and go test, 30-s sit to stand test, and 40 m self-paced walk
test22e25. We assessed change in these outcomes from baseline to
1-year follow-up.
We classiﬁed participants as OMERACTeOARSI responders or
non-responders18,19. The OMERACTeOARSI responder criteria are
(1) 50% improvement in pain or function and an absolute
improvement of 20, or (2) improvement in at least two of the
following three scores: pain 20% and absolute change 10;
function 20% and absolute change 10; global assessment 20%
and absolute change 10. We calculated OMERACTeOARSI
response using the WOMAC pain and WOMAC function subscales,
and the global rating of change instrument21. We recorded the
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ﬁed these with the New Zealand National Joint Register26. We
tracked and classiﬁed adverse events, deﬁned according to the
World Health Organization (adapted from WHO adverse event
report and serious adverse event forms).
Follow-up
Assessors blind to group allocation performed assessments at
baseline, 9 weeks, 6 months and 1 year.
Sample size
We calculated the sample size to detect a minimum clinically
important difference of 28 WOMAC points for each of the main
effects, namely, manual therapy vs no manual therapy, and exercise
therapy vs no exercise therapy27,28. We assumed a standard devi-
ation (SD) of 50 points4,5 and a type I error rate of 5%. These as-
sumptions estimated a sample of 180 participants would be needed
to detect themain effects with approximately 95% power, providing
46% power to detect an interaction and 75% power for cell-by-cell
analysis of the active interventions vs control. Allowing for 20%
attrition, we planned to recruit 224 participants. Eleven months
after the start of the trial, based on higher than expected retention
rates at follow-up, a new sample size calculation showed that,
allowing for 10% attrition, only 200 participants were required.
Statistical methods
Analyses subsets
Our initial analysis used the intention-to-treat principle, how-
ever as joint replacement surgery is a major confounding, non-
study intervention, we planned analysis of data for all partici-
pants who did not have hip or knee replacement surgery during the
1-year follow-up period. All participants were followed and
assessed through to the conclusion of the trial, irrespective of
completing the study interventions or having joint replacement
surgery. Missing data were replaced by multiple imputation using
mi in the statistical software package Stata (StataCorp)29e32. We
followed procedures to determine if missing data were ‘missing
completely at random’, and missing data patterns were examined
to determine appropriate strategies for imputation of each variable.
For each variable with missing values, 36 imputations of missing
values were generated. Estimates were checked to verify that
imputed values did not deviate signiﬁcantly from observed data in
mean value, SD, minimum and maximum values.
Primary analysis
We evaluated the effectiveness of exercise therapy vs no exer-
cise therapy and manual therapy vs no manual therapy on patient-
reported outcome (WOMAC composite score) at 1 year using
methods recommended for factorial trials, including investigation
of whether there was an interaction between the two in-
terventions33e35. We used general linear regression models
adjusted for baseline WOMAC score, stratiﬁcation variable (hip or
knee condition), and pre-speciﬁed potential confounding factors at
baseline11,36: age, bodymass index, number of years since symptom
onset, quadriceps muscle strength (measured in kg by hand-held
dynamometer), mental health (using the two question depression
screening test and classiﬁed as low risk or elevated risk: score ¼ 0,
score ¼ 1 or 2, respectively)37, and self-efﬁcacy assessed using the
pain belief screening instrument (PBSI)38,39.
While adjusted effects were the primary analysis we also report
unadjusted estimates. All tests were two sided with a 5% level of
signiﬁcance. No statistical adjustment was made for multiple
testing.Secondary analyses
Secondary analyses of the primary outcome measure (WOMAC)
were undertaken using general linear regression. To limit the
problem of multiple comparisons we do not report statistical
comparison testing of the secondary outcome measures. Instead,
we report conﬁdence intervals (CI) around the estimates for each
secondary outcome measure, by group. We also used chi square
tests where appropriate. We calculated the number needed to treat
to achieve one OMERACTeOARSI responder18,19. We assessed
whether the effects of the two interventions differed by the con-
dition (hip or knee OA). Other analyses pre-speciﬁed in the trial
protocol will be reported separately. In particular, the economic
evaluation is reported as a companion paper and the 2-year out-
comes will be reported subsequently.
Results
Recruitment commenced April 2008 and concluded March
2009. One-year follow-up was completed March 2010. Fig. 1 il-
lustrates participant ﬂow through the trial. The baseline charac-
teristics of the 206 participants are reported in Table I. Mean age
was 66 years (range 37e92), and mean (SD) WOMAC composite
score was 100.8 (53.8) at baseline. We recruited 116 participants
from primary care, with WOMAC scores of 80.61 (51.03), and 90
from secondary care (127.30 (47.70)). A total of 44 (21%) partici-
pants had replacement surgery of the index hip or knee during
the trial. We retained 193 (93.2%) of all participants at 1-year
follow-up.
The intention to treat factorial analysis for all participants
indicated a statistically signiﬁcant difference between WOMAC
scores at 1 year for manual therapy vs no manual therapy, in
addition to usual care (P ¼ 0.030 adjusted, 0.027 unadjusted), but
did not reach signiﬁcance for exercise therapy vs no exercise
therapy (P ¼ 0.061 adjusted, 0.079 unadjusted). There was a large
antagonistic interaction between manual therapy and exercise
therapy [coefﬁcient (SE) of interaction term 22.9 (12.6), P ¼ 0.072
in adjusted model with all participants, P ¼ 0.066 unadjusted].
For participants who did not have joint replacement surgery
during the trial, differences between WOMAC scores at 1 year for
manual therapy vs no manual therapy (P < 0.001) and exercise
therapy vs no exercise therapy (P ¼ 0.031) were both statistically
signiﬁcant. Again there was a large antagonistic interaction effect
(coefﬁcient 28.7, SE 11.3, P ¼ 0.012). Therefore we also present
here the “inside the table” analyses comparing usual care alone vs
manual therapy in addition to usual care, exercise therapy in
addition to usual care, and the combined therapies in addition to
usual care33e35,40,41.
In the intention to treat analysis, all interventiongroups improved
but only usual care plus manual therapy and usual care plus exercise
therapy achieved clinically signiﬁcant reductions of >28 WOMAC
points frombaseline (Table II). The usual care plus combined therapy
groupalso improved frombaselinebut failed tomeetour criterion for
clinical signiﬁcance (mean 27.4, SD 41.1). The gains over usual care
alone were 28.5 (95% CI 9.2 to 47.8) points for manual therapy, 16.4
(3.2 to 35.9) points for exercise therapy, and 14.5 (5.2 to 34.1)
points for the combined therapies programme (Fig. 2).
For participants with no joint replacement surgery during the
trial, compared with usual care alone there was a statistically sig-
niﬁcant improvement in WOMAC scores for all three interventions
(mean reduction 31.9 (16.2 to 47.7) for manual therapy, 16.3 (95% CI
0.3 to 32.2) for exercise therapy, 18.9 (2.7 to 35.2) for the combined
therapies).
The effects of the three physiotherapy interventions onWOMAC
scores were not statistically different by joint affected (hip vs knee
term in main general linear regression models for all participants
Table I
Characteristics of participants at entry to the trial*
Usual care
control
(n ¼ 51)
Usual care plus
manual therapy
(n ¼ 54)
Usual care plus
exercise therapy
(n ¼ 51)
Usual care plus
combined exercise þ
manual therapy (n ¼ 50)
Demographic
Men, n (% of group) 26 (51.0) 26 (48.1) 19 (37.3) 21 (42.0)
Women, n (% of group) 25 (49.0) 28 (51.9) 32 (62.7) 29 (58.0)
Age (years) 66.1 (10.7) 67.3 (10.2) 66.9 (8.2) 66.0 (8.9)
Body mass index (kg/m2) 29.5 (5.8) 29.2 (5.9) 29.3 (6.0) 30.1 (5.4)
Clinical
WOMAC score (range 0e240, lower scores
represent less pain, stiffness and disability)
93.8 (52.8) 114.8 (56.3) 95.5 (57.3) 99.1 (48.8)
Timed up and go test (s) 7.69 (3.26) 7.68 (3.07) 7.50 (3.14) 6.88 (2.33
30-s sit to stand test (no. of stands) 9.65 (4.29) 9.80 (4.54) 10.39 (4.37) 10.60 (3.79)
40 m self-paced walk time (s) 33.21 (12.42) 33.67 (10.18) 33.42 (11.14) 30.93 (8.37)
Pain intensity score (range 0e10, higher scores
represent more pain)
3.1 (2.0) 4.2 (2.3) 3.5 (2.0) 4.0 (2.1)
Quadriceps muscle strength (kg/kg body mass) 0.21 (0.12) 0.20 (0.09) 0.20 (0.07) 0.20 (0.08)
Duration since ﬁrst diagnosis of OA (years) 2.8 (1.3) 2.5 (1.4) 2.6 (1.4) 2.9 (1.3)
Mental health (depression screening test) score
indicates low risk of depression, n (% of group)
26 (51.0) 27 (50.9) 27 (52.9) 28 (56.0)
Hip OA, n (% of group) 23 (45.1) 24 (44.4) 22 (43.1) 21 (42.0)
Knee OA, n (% of group) 28 (54.9) 30 (55.6) 29 (56.9) 29 (58.0)
Both hip and knee OA, n (% of group) 13 (25.5) 12 (22.2) 10 (19.6) 17 (34.0)
WOMAC denotes Western Ontario and McMaster osteoarthritis index.
* Values are mean (SD) unless speciﬁed otherwise.
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P¼ 0.250). Irrespective of joint affected the greatest mean response
was seen with usual care plus manual therapy (Table III). Beneﬁts
were seen at 9-week follow-up and maintained to 6 months and 1
year (Fig. 2).
Of the participants randomised to the three active intervention
groups, 88.3% attended of at least 80% of scheduled intervention
visits, and 42.8% returned logbooks demonstrating compliance
with their programme of reinforcing activities at home. One par-
ticipant randomised to usual care sought four or more non-trial
physiotherapy visits. Per-protocol analyses of the primary out-
come (WOMAC) for compliant participants are presented in
Table III.
Secondary outcomes also showed consistent beneﬁts favouring
all three physiotherapy interventions in addition to usual care
(Table IV). Outcomes of the physical performance tests (timed up
and go, 30 s sit to stand, 40 m self-paced walk) favoured exercise
therapy in addition to usual care. The proportion of OMERACTe
OARSI responders in the three intervention groups differed from
than in the usual care only group. The numbers needed to treat to
achieve one OMERACTeOARSI responder are reported in Table IV.
The proportion of participants proceeding to joint replacement
surgery at 1 year did not differ signiﬁcantly between the groups
(P ¼ 0.65) (Table IV). We detected no trial-related serious adverse
events. We detected one adverse event in the combined therapy
group, related to exercise therapy (inguinal hernia).Table II
Mean (SD) WOMAC scores at 1-year follow-up and change in score from baseline
Usual care
control
Usual
manu
WOMAC score
No hip or knee replacement (n ¼ 162) 89.8 (56.7) 75.8
All participants (n ¼ 206) 80.9 (57.7) 73.3
Change in WOMAC score from baseline
No hip or knee replacement (n ¼ 162) 3.7 (33.4) 28.2
All participants (n ¼ 206) 12.9 (51.8) 41.4
WOMAC denotesWestern Ontario andMcMaster osteoarthritis index. Negative change re
variable (hip or knee condition), age, body mass index, symptom duration, quadriceps mDiscussion
This randomised clinical trial investigated the additional
effectiveness of three physiotherapy intervention protocols in
addition to usual care, over usual care alone. We retained 93.2%
of the trial participants to 1-year of follow-up. We have shown
that both manual physiotherapy and exercise physiotherapy in
addition to usual care produce signiﬁcant improvements in
symptoms and physical function, respectively, in patients with
moderate to severe OA of the hips or knees. The improvements in
pain and disability were evident at 9 weeks and sustained for
a year.
In our intention to treat analysis we included all participants.
Usual care plus manual therapy showed clinically and statistically
signiﬁcant improvements in the primary outcome e change in
WOMAC score e compared with usual care alone, while usual care
plus exercise therapy showed signiﬁcant improvements in all three
physical performance outcome measures. Joint replacement sur-
gery signiﬁcantly affects both pain and disability and was therefore
identiﬁed a priori as an important confounding factor42e44. When
we analysed the primary outcome (WOMAC) data excluding the 44
participants who had a joint replacement during the trial, both
manual therapy and exercise therapy showed statistically signiﬁ-
cant beneﬁt.
Exercise is an established effective therapy, however the most
effective formof this therapy is not clear and recommendationshavecare plus
al therapy
Usual care plus
exercise therapy
Usual care plus combined
exercise þ manual therapy
(55.4) 72.7 (54.4) 80.3 (51.8)
(54.9) 66.3 (54.6) 71.7 (50.0)
(46.0) 12.6 (31.0) 15.3 (34.4)
(55.5) 29.3 (50.4) 27.4 (41.1)
presents improvement. Results are adjusted for baselineWOMAC score, stratiﬁcation
uscle strength, depression, and self-efﬁcacy.
Fig. 2. Mean WOMAC score at baseline 9 weeks, 6 months and 1 year for (a) participants with no joint replacement surgery during the trial (n ¼ 162) and (b) all participants
(n ¼ 206). Note: all participants continued to receive usual medical care throughout the trial.
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pervised, individually prescribed, progressive multi-modal exercise
programme, in addition to usual care, produces sustained beneﬁt to
1-year follow-up, with respect to physical performance tests in all
participants andalso self-reportedmeasures inparticipantswhodid
not have joint replacement surgery during the trial.
Our results are consistent with those of Hoeksma et al., who
found manual therapy to be superior to exercise therapy for pa-
tients with hip OA6. While our trial was not intended to compare
these two modes of physiotherapy, and the comparison was not
tested statistically, in terms of mean effect the manual physi-
otherapy packages of care delivered in our trial provided greater
reductions in WOMAC scores than did exercise therapy. This was
the case for both hip OA and knee OA. Both programmes required
nine supervised sessions at a physiotherapy centre, in addition to
usual care, with recommendations that the participants also com-
plete a prescribed programme of reinforcing activities three times
a week at home.
The combination of exercise and manual therapy did not
produce additional beneﬁt. There was a signiﬁcant antagonistic
interaction between the two interventions and the combinationTable III
Mean (95% CI) change in WOMAC score from baseline to 1-year follow-up by joint affecte
participants with hip and knee OA who did not have joint replacement surgery during t
Usual care control
(n ¼ 43)
Usual car
therapy (
Hip OA (n ¼ 61) 6.6 (13.2 to 26.4) 22.9 (
Knee OA (n ¼ 101) 1.6 (10.5 to 13.7) 31.5 (
Compliant with attendance to >80%
of scheduled treatment visits (n ¼ 143)
e 36.9 (
Compliant with home reinforcing
activities >60% (logbook) (n ¼ 96)
e 30.1 (
WOMAC denotesWestern Ontario andMcMaster osteoarthritis index. Negative change re
variable (hip or knee condition), age, body mass index, symptom duration, quadriceps mu
analysis excluded participants in the active intervention groups not compliant at the le
physiotherapy visits.was generally less effective, or at best no more effective, than
either intervention alone. These results are consistent with those
of Deyle et al., who, in patients with knee OA, initially found
a programme of manual therapy plus exercise therapy to be su-
perior to placebo5, however in a subsequent trial comparing the
same intervention to an unsupervised home exercise programme,
no signiﬁcant difference was seen at 1 year4. The independent
contributions of exercise therapy or manual therapy cannot be
ascertained from the two trials by Deyle et al. In patients with
knee OA in our trial, the combination of manual therapy plus
exercise therapy was associated with non-signiﬁcantly greater
mean WOMAC gains than was exercise therapy alone (20.9 vs 14.3
WOMAC points over usual care), but manual therapy alone was
associated with the greatest gains (33.1 WOMAC points over usual
care). It is probable that those in the combined therapy group
spent less time on each intervention than did those who received
only one intervention, and hence decreased the effectiveness of
both modalities.
A limitation of this trial is that, due to the adverse interaction
between the two main effects, we must rely on the “inside the ta-
ble” analyses comparing each of the three intervention groupsd, and per-protocol analysis of change in WOMAC among compliers to treatment, for
he trial
e plus manual
n ¼ 42)
Usual care plus
exercise therapy (n ¼ 40)
Usual care plus
combined exercise þ
manual therapy (n ¼ 37)
43.3 to 2.6) 12.4 (27.1 to 2.3) 7.9 (30.9 to 15.3)
52.7 to 10.3) 12.7 (27.1 to 1.7) 19.3 (33.7 to 4.9)
53.4 to 20.4) 21.5 (37.8 to 5.2) 17.6 (34.5 to 0.6)
50.2 to 10.0) 17.0 (35.4 to 1.4) 14.7 (33.7 to 4.4)
presents improvement. Results are adjusted for baselineWOMAC score, stratiﬁcation
scle strength, depression, and self-efﬁcacy. Dashe denotes not applicable. Compliers
vel stated and one participant in the control group contaminated by >4 non-trial
Table IV
Changes in secondary outcome measures from baseline to 1-year follow-up. Values are mean change in test score (or time) from baseline to 1 year (95% CI) unless speciﬁed
otherwise
Secondary outcome Usual care control Usual care plus
manual therapy
Usual care plus
exercise therapy
Usual care plus combined
exercise þ manual therapy
Timed up and go test (s)*
No hip or knee replacement (n ¼ 162) 0.51 0.08 0.87 0.28
(0.42 to 1.43) (0.94 to 1.10) (1.32 to 0.42) (0.73 to 0.16)
All participants (n ¼ 206) 0.03 0.17 1.03 0.22
(0.94 to 0.88) (1.00 to 0.67) (1.54 to 0.52) (0.64 to 0.19)
30-s sit to stand test (no of stands)y
No hip or knee replacement (n ¼ 162) 0.02 0.67 1.60 1.59
(0.79 to 0.84) (0.12 to 1.45) (0.80 to 2.40) (0.60 to 2.59)
All participants (n ¼ 206) 0.59 0.76 1.47 1.74
(0.25 to 1.42) (0.04 to 1.56) (0.65 to 2.29) (0.85 to 2.63)
40 m self-paced walk time (s)*
No hip or knee replacement (n ¼ 162) 0.78 0.50 3.18 0.61
(1.40 to 2.95) (3.70 to 2.70) (4.41 to 1.94) (2.22 to 1.00)
All participants (n ¼ 206) 0.63 1.68 4.78 1.07
(2.90 to 1.64) (4.39 to 1.02) (7.03 to 2.54) (2.48 to 0.34)
Pain intensity score (range 0e10, negative scores indicate reduced pain)
No hip or knee replacement (n ¼ 162) 0.35 1.10 0.45 0.84
(0.26 to 0.96) (2.09 to 0.11) (1.14 to 0.24) (1.70 to 0.28)
All participants (n ¼ 206) 0.06 1.52 0.96 1.58
(0.71 to 0.60) (2.42 to 0.62) (1.65 to 0.27) (2.40 to 0.76)
OMERACTeOARSI responders, no (% of group)
No hip or knee replacement (n ¼ 162) 10 (23.3%) 21 (50.0%) 16 (40.0%) 12 (32.4%)
All participants (n ¼ 206) 18 (35.3%) 31 (57.4%) 26 (51.0%) 24 (48.0%)
Relative risk for surpassing OMERACTeOARSI response criteria, RR (95% CI)
No hip or knee replacement (n ¼ 162) e 2.15 (1.15 to 4.00) 1.72 (0.89 to 3.34) 1.39 (0.68 to 2.85)
All participants (n ¼ 206) e 1.63 (1.05 to 2.52) 1.44 (0.92 to 2.29) 1.36 (0.85 to 2.18)
Number needed to treatz
No hip or knee replacement (n ¼ 162) e 4 (2 to 17) 6 (3 to N) 11 (3 toN)
All participants (n ¼ 206) e 5 (2 to 29) 6 (3 to N) 8 (3 toN)
Adverse events, no (% of group)
No hip or knee replacement (n ¼ 162) 1x 0 0 1x
All participants (n ¼ 206) 1x 0 0 3{
Joint replacement surgeries, no (% of group)
All participants (n ¼ 206) 8 (15.7%) 12 (22.2%) 11 (21.6%) 13 (26.0%)
OMERACTeOARSI denotes Outcome Measures in Rheumatoid Arthritis Clinical Trials e Osteoarthritis Research Society International.
* Negative times represent shorter time to complete, indicating improvement.
y Positive values represent more repetitions, indicating improvement.
z Values are the number needed to treat to achieve one OMERACTeOARSI responder.
x Non-trial related death.
{ One possibly trial related inguinal hernia associated with exercise; one non-trial related post-operative complication following total knee arthroplasty; one non-trial
related death.
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addition to usual care, and the combined therapies in addition to
usual care) to the usual care only control. As we did not make ad-
justments for multiple comparisons, our results should be limited
to interpretation as generating a hypothesis that both manual
therapy and exercise therapy are effective interventions for hip and
knee OA, and should not be considered conﬁrmatory evidence of
efﬁcacy. Multiple statistical comparisons can limit the inter-
pretation of some trials: we limited the potential impact of this by
pre-specifying our primary and secondary comparisons11, limiting
the comparisonsmade to comparing the primary outcomemeasure
in each active intervention group to the usual care control only,
refraining from testing at multiple endpoints, not attempting
comparisons between sub-groups (other than the stratiﬁcation
factor), and not conducting comparisons of the secondary outcome
measures, instead reporting CI around group estimates. There re-
mains, however, the risk of positive results arising by chance alone,
particularly among the secondary outcomes.
In terms of other limitations, it is possible that the physiothera-
pists delivering the interventions may have exerted bias dis-
advantaging one or more of the active intervention arms. We think
this unlikely, however, because although exercise physiotherapy, in
addition to usual care, did not provide clinically or statistically sig-
niﬁcant changes compared with usual care alone, on the primary
patient-reported outcome measure, physical performance testresults strongly favoured those in the exercise therapy group. This
ﬁnding is consistent with evidence that self-reported measures of
outcome, such as the WOMAC, capture different constructs of phys-
ical function compared with physical performance tests, leading to
recommendations that bothmeasures of outcome are necessary and
important45e47. The effect of joint replacement surgery, an un-
planned, non-randomised co-intervention, has the potential to limit
interpretation of the effects of the trial interventions. As it has the
effect of inﬂuencing the primary outcome (WOMAC score) down-
ward (as shown in Table II), we suggest that the subgroup analyses
excluding those participants who had joint replacement surgery is
likely to be a more accurate estimate of the effects of the trial in-
terventions. In that analysis, exercise therapy showed signiﬁcant ef-
fectonboth theprimaryoutcome (WOMAC)andquality-adjusted life
years (QALYs) gained, as reported separately in the economic evalu-
ation conducted alongside this trial.16 Our compliance analysis is
limited by low return of the logbookused for participants’ self-report
of compliance with their prescribed programme of reinforcing ac-
tivities at home. This gives the impression of poor compliance with
the prescribed programme of reinforcing activities, however our
anecdotal impression from speakingwith participants was that they
may have been more compliant with doing their home reinforcing
activities than theywerewithﬁllingoutandreturning their logbooks.
We therefore advise caution interpreting compliance to the home
programme, and the associated subgroup analysis of compliers.
J.H. Abbott et al. / Osteoarthritis and Cartilage 21 (2013) 525e534532Our study was not intended to directly compare the physi-
otherapy interventions. As both manual therapy and exercise
therapy appear effective, in addition to usual care alone, depending
on the outcome of interest, the choice of therapy should be deter-
mined by patient characteristics and patient choice. The addition of
manual therapy to usual care confers patient-reported beneﬁt (on
the WOMAC), while exercise therapy confers physical performance
beneﬁts. This may inﬂuence patient choice. Patient characteristics
that might favour manual therapy include restricted active and
passive joint motion, while factors that might favour exercise
therapy include lower limb skeletal muscle atrophy and lowaerobic
ﬁtness, however there is little evidence as yet to support these
suggestions48,49. Our results do not support the use of both in-
terventions within a single treatment session, as our combination
therapy group generally showed lower mean gains than either
manual therapy or exercise therapy alone. We therefore recom-
mend that therapists ensure that adequate time is dedicated to
delivering each individual intervention. In our protocols this
involved nine approximately 50 min sessions (seven sessions in the
ﬁrst 9 weeks, then two booster sessions after a further 7 weeks) of
interventions that started at a high enough level to challenge the
limits of the individual patient. They were gradually progressed to
higher levels of resistance, stretch, repetitions, difﬁculty and/or
duration, such that the programme remained challenging and
continued to progressively stimulate physiological change. It
should not be assumed that our ﬁndings would be applicable to
delivery of truncated or deviating protocols.
In conclusion, we have shown that manual physiotherapy pro-
vided signiﬁcant, clinically important and sustained improvements
in symptoms for patients with OA of hips or knees. Exercise phys-
iotherapy also provided sustained beneﬁt, with respect to physical
performance tests in all participants and both self-reported mea-
sures and physical performance tests in participants who did not
have joint replacement surgery during the trial. While not deﬁni-
tive, these ﬁndings indicate that our manual physiotherapy and
exercise therapy protocols may be efﬁcacious treatments for pa-
tients with hip and knee OA, to improve function and relieve
symptoms prior to considering joint replacement surgery, but not
both treatments delivered in the same treatment sessions. These
results require conﬁrmation.
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